The Journal of Antibiotics · 1978 · 15 citations · 9 references
Life SciencesInfectious DiseasesPharmacologyAntimicrobial PharmacologyAntimicrobial ResistanceDrug DiscoveryAntibiotic ResistanceBeta-lactam ResistanceResistance In Gram-negative BacteriaResistance In Gram-positive BacteriaAminoglycoside AntibioticsAminoglycoside Resistance MechanismsSpectrum Of Aminoglycosides
1-N HAPA gentamicin B is a new aminoglycoside active against most Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus. Among 504 clinical isolates at a concentration of 12.5 microgram/ml all Staph. aureus, Escherichia coli, Klebsiella, Enterobacter, Proteus rettgeri, Providencia and 78% of Pseudomonas, 86% of Proteus morganii were inhibited. Like other aminoglycosides, the activity was greatest at an alkaline ph and reduced by high cations concentrations. 1-N HAPA gentamicin B was equal in activity to amikacin against both gentamicin-sensitive and resistant isolates. It inhibited bacteria containing many of the aminoglycoside inactivating enzymes. When combined with carbenicillin it inhibited in a synergistic manner many Gram-negative bacteria, particularly Pseudomonas and Serratia.
9
David N. Gilbert, E. Kutscher, Paddy Ireland et al. · The Journal of Infectious Diseases · 1971 · 96 citations
Veterinary Medicine, Infectious Diseases, Antimicrobial Pharmacotherapy +8
Ototoxicity of Tobramycin: A Clinical Overview
Harold C. Neu, C. L. Bendush · The Journal of Infectious Diseases · 1976 · 65 citations
Medicine, Audiology, Otolaryngology +15